WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) today announced that Dominick Colangelo has resigned to pursue another employment opportunity. Subsequently, the Oscient corporate officer team will include Steve Rauscher, CEO and President; Philippe Maitre, EVP and Chief Financial Officer; and Mark Glickman, SVP, Sales and Marketing.
